WASHINGTON – House lawmakers on Tuesday floated reforms to a controversial drug discount program serving low-income populations, but it’s still unclear which policies will come …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.